Ignite Creation Date:
2024-05-06 @ 1:11 PM
Last Modification Date:
2024-10-26 @ 1:10 PM
Study NCT ID:
NCT03959085
Status:
RECRUITING
Last Update Posted:
2024-04-22
First Post:
2019-05-20
Brief Title:
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL Mixed Phenotype Acute Leukemia and B-LLy
Sponsor:
Organization:
Childrens Oncology Group